Validation of the Korean Migraine-Specific Quality of Life Questionnaire Version 2.1 in Episodic and Chronic Migraine

2017 ◽  
Vol 31 (3) ◽  
pp. 251-256 ◽  
Author(s):  
Jong-Geun Seo ◽  
Sung-Pa Park
Keyword(s):  
Quality Of Life ◽  
Chronic Migraine ◽  
Life Questionnaire ◽  
Quality Of Life Questionnaire ◽  
Questionnaire Version

Validation of Cancer Institute Quality of Life Questionnaire Version II for cancer patients in India

2011 ◽  
Vol 48 (4) ◽  
pp. 500 ◽  
Author(s):  
E Vidhubala ◽  
R Ravikannan ◽  
R Muthuvel ◽  
FU John Paul ◽  
Latha ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Cancer Patients ◽  
Life Questionnaire ◽  
Quality Of Life Questionnaire ◽  
Questionnaire Version

Validating the Migraine-Specific Quality of Life Questionnaire v2.1 (MSQ) in Italian inpatients with chronic migraine with a history of medication overuse

2013 ◽  
Vol 23 (4) ◽  
pp. 1273-1277 ◽  
Author(s):  
Alberto Raggi ◽  
Ambra Mara Giovannetti ◽  
Silvia Schiavolin ◽  
Matilde Leonardi ◽  
Gennaro Bussone ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Chronic Migraine ◽  
Medication Overuse ◽  
Life Questionnaire ◽  
Quality Of Life Questionnaire ◽  
History Of

scholarly journals PND26 VALIDATING USE OF THE MIGRAINE-SPECIFIC QUALITY OF LIFE QUESTIONNAIRE VERSION 2.1 (MSQ) ACROSS MIGRAINE DISORDERS

2010 ◽  
Vol 13 (3) ◽  
pp. A142 ◽  
Author(s):  
CL Elson ◽  
GA Maglinte ◽  
R Rendas-Baum ◽  
M DeRosa ◽  
M Yang ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Life Questionnaire ◽  
Migraine Disorders ◽  
Quality Of Life Questionnaire ◽  
Questionnaire Version

Minimal Important Differences in the Migraine-Specific Quality of Life Questionnaire (MSQ) Version 2.1

Cephalalgia ◽  
2009 ◽  
Vol 29 (11) ◽  
pp. 1180-1187 ◽  
Author(s):  
JC Cole ◽  
P Lin ◽  
MFT Rupnow
Keyword(s):  
Quality Of Life ◽  
Life Questionnaire ◽  
Group Level ◽  
Future Studies ◽  
Individual Level ◽  
Quality Of Life Questionnaire ◽  
Large Databases ◽  
Questionnaire Version ◽  
Minimal Important Differences

To propose minimal important differences (MID) for the Migraine-Specific Quality of Life Questionnaire version 2.1 (MSQ v2.1). To our knowledge (to date), no published MID values exist for the MSQ v2.1 in any population. Analyses were performed on data from two pivotal clinical trials of topiramate for migraine prevention ( n = 916), as well as from the QualityMetric National Headache Survey ( n = 1016). Analyses included both distribution- and anchor- based MID techniques as well as group- and individual-level MID values. Group-level anchor-based MID values ranged from 3.2 [Role Restrictive domain (RR)] to 7.5 [Emotional Functioning domain (EF)], setting the minimum level of appropriate MID (which can also aid with power analysis). Individual-level distribution-based MID values resulted in highly similar estimates from two large databases: median MID of 8.5 for RR, 9.2 for Role Preventive (RP) and 12.0 for EF. Finally, individual-level anchor-based MID values ranged from 5.0 (RR and RP domains) to 10.6 (EF). For group-level purposes of calculating power for future studies, an MID of 3.2, 4.6 and 7.5 for RR, RP and EF is recommended. For within-group analyses for analysing clinical trial efficacy of each patient's change with responder analyses, 5 points is necessary for RR. For RP and EF, ranges are recommended: 5.0 to 7.9 for RP and 8.0 to 10.6 for EF. These latter two domains tend to have more error in the MID, and thus a sensitivity analysis with both ends of the range should be used to confirm significant differences in responder analyses.

Validating Migraine-Specific Quality of Life Questionnaire v2.1 in Episodic and Chronic Migraine

2011 ◽  
Vol 52 (3) ◽  
pp. 409-421 ◽  
Author(s):  
Christine L. Bagley ◽  
Regina Rendas-Baum ◽  
Gregory A. Maglinte ◽  
Min Yang ◽  
Sepideh F. Varon ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Chronic Migraine ◽  
Life Questionnaire ◽  
Quality Of Life Questionnaire
Sign in / Sign up

Export Citation Format

Share Document